Skip to Main Content

INTRODUCTION

sertaconazole (ser-ta-kon-a-zole)

Ertaczo

Classification

Therapeutic: antifungals

Pharmacologic: imidazoles

Indications

Topical treatment of interdigital tinea pedis in immunocompetent patients >12 yr.

Action

Inhibits synthesis of ergosterol, a component of fungal cell membrane, resulting in cytoplasmic leakage and fungal cell death. Therapeutic Effects: Resolution of fungal infection. Spectrum: Active against Trichophyton rubrum, T. mentagrophytes, Epidermophyton floccosum.

Adverse Reactions/Side Effects

Derm: application site reactions, burning, contact dermatitis, dry skin, tenderness.

PHYSICAL THERAPY IMPLICATIONS

Examination and Evaluation

  • Assess healing of skin lesions to help document drug effectiveness.

Interventions

  • Avoid contact with cutaneous lesions when treating patient.

  • Always wash hands thoroughly and disinfect equipment (whirlpools, electrotherapeutic devices, treatment tables, and so forth) to help prevent the spread of infection.

Patient/Client-Related Instruction

  • Advise patient to report any increased local sensitivity to this drug (pain, burning, itching, swelling).

  • Instruct patient about proper hygiene; e.g., thoroughly wash and dry the affected area, wear clean socks and ventilated shoes for tinea pedis, and so forth.

  • Advise patient to apply the drug as directed for the full course of treatment even if feeling better.

  • Inform patient that full therapeutic response may take up to 4 wk.

  • Advise patient to seek medical help if infections persist or recur after the full treatment. Recurrent fungal infections may be a sign of systemic illness.

Pharmacokinetics

Absorption: Minimal systemic absorption.

Distribution: Unknown.

Metabolism and Excretion: Unknown.

Half-life: Unknown.

Favorite Table | Download (.pdf) | Print

TIME/ACTION PROFILE

ROUTE ONSET PEAK DURATION
topical within 2 wk unknown unknown

Contraindications/Precautions

Contraindicated in: Hypersensitivity to sertaconazole or other imidazoles.

Use Cautiously in: Children <12 yr, lactation (safety not established); Pregnancy (use only if clearly needed).

Interactions

Drug-Drug: None noted.

Route/Dosage

Topical (Adults and Children >12 yr): Apply bid for 4 wk.

Availability

2% cream: 15-g tube, 30-g tube.

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.